Two Top Stories of NYSE: CA, Inc. (NASDAQ:CA), ImmunoGen, Inc. (NASDAQ:IMGN)


The shares of CA, Inc. (NASDAQ:CA) traded with the day volume of 2.51 Million shares whereas its average trading volume is 2.6 Million.

While analyzing the past performance of the stock we can see that the shares of CA, Inc. (NASDAQ:CA) Loss -2.4% in the last week while rising 0.17% in the last month. Past quarter performance shows the green light with 5.01%. The semi-annual and annual performance shows 7.31% and 9.43% respectively.

Some critical values of the shares of CA, Inc. (NASDAQ:CA) to be discussed here are: the beta which shows the value at 0.68 while Average True Range of CA, Inc. (NASDAQ:CA) demonstrate the value at 0.65. The weekly and monthly volatility of the shares of CA, Inc. (NASDAQ:CA) are indicated at 1.67% and 1.62%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 49.92.

While studying the financial position of the shares of CA, Inc. (NASDAQ:CA), we can see that the Market capitalization of the company is at 14.72 Billion. The shares outstanding for the company is 415.76 Million and the shares float stands at 312.33 Million. The income of the company stand at 737 Million while the sales stand at 4.16 Billion.

Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at 1.78, Price to Earnings or P/E is at 19.94, Price to Sales P/S show the value of 3.53, the Return on Asset ROA stood at 0.034 and the Return on Equity ROE depicted at 0.072 while Return on Investment ROI is at 0.099.


View all contributions by

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

    Leave a Comment